Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.
Published April 20, 2022 · Recall initiated: April 5, 2022
Summary
FDA records drug Class III recall D-0766-2022, published April 20, 2022 and initiated April 5, 2022. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 433,809 vials; Lot: Lots: CCC210004, Exp 09/2022; CCC210005, CCC210006, CCC210007, Exp 11/2022; CCC210010, CCC210011, Exp 04/2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Out of Specification results for Assay
What to do
Voluntary: Firm initiated
Get an email if CYANOCOBALAMIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CYANOCOBALAMIN
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- Nationwide in the USA.
- UPC
- 0355150364015
- Lot
- Lots: CCC210004, Exp 09/2022; CCC210005, CCC210006, CCC210007, Exp 11/2022; CCC210010, CCC210011, Exp 04/2023.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACyanocobalamin injection USP, 10,000 mcg/10 mL (1,000 mcg/mL), For IM or SC Use Only, packaged in a) 10 mLAugust 26, 2026
- FDACyanocobalamin injection USP, 1,000 mcg/mL, For IM or SC Use Only, packaged in a) 1 mL Multi-Dose Vial (NDCAugust 26, 2026
- FDAIDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only,April 20, 2022
- FDAClobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent Pharma, Inc.,April 20, 2022
- FDAFirst SIGN SARS-CoV-2 Antigen TestApril 13, 2022
- FDACYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APPDecember 17, 2014
Questions about this recall
Was Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01. recalled?
Yes. FDA published recall D-0766-2022 on April 20, 2022. Reported hazard: Subpotent Drug: Out of Specification results for Assay
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CYANOCOBALAMIN. UPC: 0355150364015.